4.7 Review

In vivo, in vitro, and in silico analysis of methylation of the HIV-1 provirus

Journal

METHODS
Volume 53, Issue 1, Pages 47-53

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ymeth.2010.05.009

Keywords

CpG Island; DNA methylation; HIV-1 latency; Bisulfite-mediated methylcytosine mapping

Funding

  1. NIGMS-IMSD [R25-GM56847]
  2. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847] Funding Source: NIH RePORTER
  3. NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030216] Funding Source: NIH RePORTER

Ask authors/readers for more resources

HIV-1 latency is a barrier to overcome in the effort to fully eradicate the virus from infected individuals using highly active anti-retroviral therapy (HAART). Therefore, the study of the mechanisms underlying the establishment and maintenance of HIV-1 latency are vital to achieving a cure. Transcriptional repression of the viral promoter is the major cause of HIV-1 latency. DNA methylation of genomic regions known as CpG islands (CpGIs) is a well-established transcriptional regulatory mechanism, and the HIV-1 provirus contains several conserved CpGIs including two that are located within the viral promoter region. The study of these CpGIs in both in vitro and in vivo models of HIV-1 latency using the technique of bisulfite-mediated methylcytosine mapping has led to their identification as factors that contribute to the maintenance of HIV-1 latency. Here, we discuss the identification of CpGIs within the HIV-1 provirus and the study of their differential methylation patterns in several HIV-1 latency models using bisulfite-mediated methylcytosine mapping. (c) 2010 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available